Please sign in to follow a disease.
GPS for your sinuses? new trial tests Navigation-Guided balloon surgery
NCT ID NCT06567821
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a navigation system during balloon sinus dilation improves success rates for people with chronic maxillary sinusitis. Fifty adults who have not had prior sinus surgery will be randomly assigned to receive either standard balloon dilation or navigation-guided dilation. The goal is to see if navigation leads to better outcomes, with an expected 30% improvement in success.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- RELIEVA SPINPLUS® NAV Balloon Sinusplasty System (navigated device)
- What this could lead to
- If it works, this could make balloon sinus dilation more accurate and effective for people with chronic sinusitis, reducing the need for more invasive surgery.
- What could go wrong
- This is a small, early-phase trial with only 50 people. The improvement may be small or not apply to everyone. Both devices are already approved, so the main question is whether navigation adds meaningful benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2024
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults 18 years of age or older * Candidate for primary endoscopic sinus surgery (ESS) for chronic maxillary rhinosinusitis without nasal polyposis (CRSwNP) * Failed medical (non-surgical) therapy Exclusion Criteria: * History of previous sinus surgery * Presence of nasal polyps * Extensive sinonasal osteogeneis * Cystic fibrosis * Presence of sinonasal tumors * Any records flagged "break the glass" or "research opt out." * Any additional finding which in the opinion of the investigator precludes patient from participating in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic maxillary rhinosinusitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cedars Sinai
RECRUITINGLos Angeles, California, 90048, United States